Opaleye Management Inc. - MEI PHARMA INC ownership

MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 112 filers reported holding MEI PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of MEI PHARMA INC
ValueSharesWeighting
Q4 2021$3,511,000
-18.7%
1,315,000
-16.0%
0.74%
-7.7%
Q3 2021$4,319,000
-3.2%
1,565,0000.0%0.81%
+8.9%
Q2 2021$4,460,000
-16.4%
1,565,000
+0.6%
0.74%
-5.5%
Q1 2021$5,337,000
+29.9%
1,556,0000.0%0.78%
+46.0%
Q4 2020$4,108,000
-15.4%
1,556,0000.0%0.54%
-43.5%
Q3 2020$4,855,000
-24.4%
1,556,0000.0%0.95%
-26.8%
Q2 2020$6,426,0001,556,0001.30%
Other shareholders
MEI PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
TLS Advisors LLC 2,010,285$4902.42%
Anson Funds Management LP 10,617,959$2,586,5350.43%
NEA Management Company, LLC 8,533,072$2,078,6560.12%
Boxer Capital, LLC 2,913,091$709,6290.04%
Investmark Advisory Group LLC 136,000$33,1300.02%
CARLSON CAPITAL L P 1,180,000$287,4480.02%
Mesirow Financial Investment Management, Inc. 20,486$4,9900.02%
Artal Group S.A. 1,000,000$2440.01%
Annandale Capital, LLC 100,000$240.01%
ACADIAN ASSET MANAGEMENT LLC 4,758,364$1,1580.01%
View complete list of MEI PHARMA INC shareholders